Abstract
Background Topical NGF eye drops (Cenegermin) were approved in 2015 as an orphan drug for the treatment of neurotrophic keratopathy (NK). The active s......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
